Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.7.3495

Diagnostic Value of Interleukin 21 and Carcinoembryonic Antigen Levels in Malignant Pleural Effusions  

Bunjhoo, Hansvin (Department of Respiratory and Critical Care Medicine, Tongji Hospital, Key Laboratory of Pulmonary Diseases of the Ministry of Health of China, Tongji Medical College, Huazhong University of Science and Technology)
Wang, Zheng-Yun (Department of Respiratory and Critical Care Medicine, Tongji Hospital, Key Laboratory of Pulmonary Diseases of the Ministry of Health of China, Tongji Medical College, Huazhong University of Science and Technology)
Chen, Hui-Long (Department of Respiratory and Critical Care Medicine, Tongji Hospital, Key Laboratory of Pulmonary Diseases of the Ministry of Health of China, Tongji Medical College, Huazhong University of Science and Technology)
Cheng, Sheng (Department of Respiratory and Critical Care Medicine, Tongji Hospital, Key Laboratory of Pulmonary Diseases of the Ministry of Health of China, Tongji Medical College, Huazhong University of Science and Technology)
Xiong, Wei-Ning (Department of Respiratory and Critical Care Medicine, Tongji Hospital, Key Laboratory of Pulmonary Diseases of the Ministry of Health of China, Tongji Medical College, Huazhong University of Science and Technology)
Xu, Yong-Jian (Department of Respiratory and Critical Care Medicine, Tongji Hospital, Key Laboratory of Pulmonary Diseases of the Ministry of Health of China, Tongji Medical College, Huazhong University of Science and Technology)
Cao, Yong (Department of Respiratory and Critical Care Medicine, Tongji Hospital, Key Laboratory of Pulmonary Diseases of the Ministry of Health of China, Tongji Medical College, Huazhong University of Science and Technology)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.7, 2012 , pp. 3495-3499 More about this Journal
Abstract
The aim of this study was to evaluate the diagnostic value of interleukin 21(IL-21) and carcinoembryonic antigen (CEA) in tuberculous pleural effusions (TPEs) and malignant pleural effusions (MPEs). Pleural effusion samples from 103 patients were classified on the basis of diagnosis as TPE (n=51) and MPE (n=52). The concentration of IL-21 was determined by ELISA. Lactate dehydrogenase (LDH), adenosine dehydrogenase (ADA) and CEA levels were also determined in all patients. A significant difference was observed in the levels of ADA and CEA (P<0.01), but not in the levels of LDH (P>0.05) between TPE and MPE. The concentration of IL-21 in MPE was significantly higher compared to TPE (P<0.01). With a threshold value of 4.32 pg/ml, IL-21 had a sensitivity of 76.9% (40/52) and a specificity of 80.4% (41/51). Combined detection of IL-21 and CEA had a sensitivity of 69.2% (36/52) and a specificity of 92.2% (47/51). These two markers can contribute to the differential diagnosis of MPEs.
Keywords
Interleukin 21; carcinoembryonic antigen; malignant pleural effusion; tuberculous pleural effusion;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lim J, Derrick SC, Kolibab K, et al (2009). Early pulmonary cytokine and chemokine responses in mice immunized with three different vaccines against Mycobacterium tuberculosis determined by PCR array. Clin Vaccine Immunol, 16, 122-6.   DOI
2 Liu Y, Helms C, Liao W, et al (2008). A genome-wide association study of Psoriasis and psoriatic arthritis identifies new gene loci. PLoS Genet, 4, e100004
3 Liu Z, Yang L, Cui Y, et al (2009). IL-21 enhances NK cell activation and cytolytic activities and induces TH17 cell differentiation in inflammatory bowel diseases. Inflamm Bowel Dis, 15, 1133-44.   DOI
4 Lucivero G, Pierucci G, Bonomo L (1988). Lymphocyte subsets in peripheral blood and pleural fluid. Eur Respir J, 1, 337-40.
5 Ma HL, Whitters MJ, Konz RF, et al (2003). IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-$\gamma$. J Immunol, 171, 608-15.   DOI
6 Maskell NA, Gleeson FV, Davies RJ (2003). Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet, 361, 1326-30.   DOI
7 Musani AI (2009). Treatment options for malignant pleural effusion. Curr Opin Pulm Med, 15, 380-7.   DOI
8 Nurieva R, Yang XO, Martinez G, et al (2007). Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature, 448, 480-3.   DOI
9 Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ (2000). Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA, 97, 11439-44.   DOI
10 Parrish-Novak J, Dillon SR, Nelson A, et al (2000). Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature, 408, 57-63.   DOI
11 Pomjanski N, Juergen Grote H, Doganay P, and et al (2005). Immunocytochemical identification of carcinomas of unknown primary in serous effusions. Diagn Cytopathol, 33, 309-15.   DOI   ScienceOn
12 Radjenovik-Petrovic T, Pejcic T, Nastasijevic-Borovac D, et al (2009). Diagnostic value of CEA in pleural effusions for differential diagnosis of benign and malignant pleural effusions. Med Arh, 63, 141-2.
13 Sriram KB, Relan V, Clarke BE, et al (2011). Diagnostic molecular biomarkers for malignant pleural effusions. Future Oncology, 7, 737-52.   DOI
14 Sarra M, Monteleone G (2010). Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus. J Biomed Biotechnol, 294, 582.
15 Sondergaard H, Frederiksen KS, Thygesen P, et al (2007). Interleukin 21 therapy increases the density of tumor infiltrating CD8(+)T cells and inhibits the growth of syngeneic tumors. Cancer Immunol ther, 56, 1417-28.   DOI
16 Sondergaard H, Skak K (2009). IL-21: roles in immunopathology and cancer therapy. Tissue Antigens, 74, 467-79.   DOI
17 Spector M, Polak JS (2008). Management of malignant pleural effusions. Semin Respir Crit Care Med, 29, 405-13.   DOI   ScienceOn
18 Spolski R, Leonard WJ (2008). Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol, 26, 57-79.   DOI
19 Wang G, Tschoi M, Spolski R, et al (2003). In vivo antitumor activity of interleukin 21 mediated by natural killer cells. Cancer Res, 63, 9016-22.
20 Wang T, Lv M, Qian Q, et al (2011). Increased frequencies of T helper type 17 cells in tuberculous pleural effusion. Tuberculosis (Edinb), 91, 231-7.   DOI
21 Westfall DE, Fan X, Marchevsky AM (2010). Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells. Diagn Cytopathol, 38, 9-14.
22 Yang HB, Shi HZ (2008). T lymphocytes in pleural effusion. Chin Med J (Engl), 121, 579-80.
23 Ye ZJ, Zhou Q, Zhang JC, et al (2011). CD39+ Regulatory T cells suppress generation and differentiation of Th-17 cells in human malignant pleural effusion via a LAP-dependent mechanism. Respir Res, 12, 77.   DOI
24 Brandt K, Singh PB, Bulfone-Paus S, Ruckert R (2007). Interleukin-21: a new modulator of immunity, infection, and cancer. Cytokine Growth Factor Rev, 18, 223-32.   DOI
25 Zhou L, Ivanov II, Spolski R, et al (2007). IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol, 8, 967-74.   DOI
26 Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007). Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol, 8, 942-9.
27 Asao H, Okuyama C, Kumaki S, et al (2001). Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol, 167, 1-5.   DOI
28 Baumann MH, Nolan R, Petrini M, et al (2007). Pleural tuberculosis in the United States: incidence and drug resistance. Chest, 131, 1125-32.   DOI
29 Boucher D, Cournoyer D, Stanners CP, Fuks A (1989). Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res, 49, 847-52.
30 Brady J, Hayakawa Y, Smyth MJ, Nutt SL (2004). IL-21 induces the functional maturation of murine NK cells. J Immunol, 172, 2048-58.   DOI
31 Casal RF, Eapen GA, Morice RC, Jimenez CA (2009). Medical thoracoscopy. Curr Opin Pulmon Med, 15, 313-20.   DOI
32 Chen Z, O'Shea JJ (2008). Th-17 cells: a new fate for differentiating helper T cells. Immunol Res, 41, 87-102.   DOI   ScienceOn
33 Coquet JM, Kyparissoudis K, Pellicci DG, et al (2007). IL-21 is produced by NKT cells and modulates NKT-cell activation and cytokine production. J Immunol, 178, 2827-34.   DOI
34 Elsaesser H, Sauer K, Brooks DG (2009). IL-21 is required to control chronic viral infections. Science, 324, 1569-72.   DOI   ScienceOn
35 Davies HE, Nicholson JE, Rahman NM, et al (2010). Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies. Eur J Cardiothorac Surg, 38, 472-7.   DOI
36 Doelken P (2008). Clinical implications of unexpandable lungs due to pleural disease. Am J Med Sci, 335, 21-5.   DOI
37 Daha NA, Kurreeman FA, Marques RB, et al (2009). Confirmation of STAT4, IL2/IL-21, CTLA4 polymorphism in Rheumatoid Arthritis. Arthritis Rheum, 60, 1255-60.   DOI
38 Ferrer J, Villarino MA, Encabo G, et al (1999). Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125 neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer, 86, 1488-95.   DOI
39 Gupta Bk, Bharat V, Bandyopadhyay D (2010). Role of adenosine desaminase estimation in differentiation of tuberculous from non tuberculous exudative pleural effusions. J Clin Med Res, 2, 79-84.
40 Furukawa J, Hara I, Nagai H, et al (2006). Interleukin-21 gene transfection into mouse bladder cancer cells results in tumor rejection through the cytotoxic T lymphocyte response. J Urol, 176, 1198-203.   DOI
41 Habib T, Senadheera S, Weinberg K, KaushanskyK (2002). The common gamma chain (${\gamma}c$) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry, 41, 8725-31.   DOI
42 Hackbarth JS, Murata K, Reilly WM, Algeciras-Schimnich A (2010). Performance of CEA and CA19-9 in identifying pleural effusions caused by malignancies. Clin Biochem, 43, 1051-5.   DOI
43 Khaleeq G, Musani AI (2008). Emerging paradigms in the management of malignant pleural effusions. Respir Med, 102, 939-48.   DOI
44 Harada M, Magara-Koyanagi K, Watarai H, et al (2006). IL -21 induced Be cell apoptosis mediated by natural killer T cells suppress IgE responses. J Exp Med, 203, 2929-37.   DOI
45 Heffner JE (2008). Diagnosis and management of malignant pleural effusions. Respirology, 13, 5-20.
46 Hoeve MA, Savage ND, de Boer T, et al (2006). Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol, 36, 661-70.   DOI
47 Korn T, Bettelli E, Gao W, et al (2007). IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature, 448, 484-7.   DOI   ScienceOn